A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence

Completed · Phase 2

Conditions studied: Methamphetamine Dependence

In brief

The proposed study will establish the safety and efficacy of modafinil in the treatment of methamphetamine dependence, as well as assess the affects of modafinil on cognitive function in methamphetamine users and on methamphetamine withdrawal symptoms. In this outpatient trial, methamphetamine- dependent, treatment-seeking subjects will receive modafinil or placebo daily for four weeks, along with weekly Motivational Enhancement Therapy sessions. This study will be conducted at the Addiction \& Pharmacology Laboratory in San Francisco, CA, and at the New Leaf Treatment Center in Lafayette, CA, and is expected to last one year.

Key facts

Study ID

NCT01354470

Run by

California Pacific Medical Center Research Institute

People needed

72

Starts

2011-10-01

Last updated by the study team

2013-07-02

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age between 18 and 50 years
• Patient is agreeable to conditions of study and signs consent form

Where it is running

• New Leaf Treatment Center — Lafayette, California, United States
• CPMC Research Institute, St.Luke's Hospital — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.